NCT05845736View on ClinicalTrials.gov

The Impact of Dementia and Neurocognitive Disorders on Hypertension Treatment in the Elderly

CompletedOBSERVATIONAL
Enrollment

353

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2022

Study Completion Date

December 12, 2022

Conditions
Neurocognitive DisordersDementiaHypertensionAged, 80 and Over
Interventions
DRUG

Antihypertensive Agents

number of hypertensive drugs

Trial Locations (1)

54000

Centre Hospitalier Régional Universitaire de Nancy, Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT05845736 - The Impact of Dementia and Neurocognitive Disorders on Hypertension Treatment in the Elderly | Biotech Hunter | Biotech Hunter